Polymerase chain reaction 양성 소아 마이코플라스마 폐렴에서 혈청 IgM enzyme-linked immunosorbent assays의 진단적 가치
Diagnostic value of serum IgM enzyme-linked immunosorbent assays in polymerase chain reaction-positive Mycoplasma pneumonia in children
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Mycoplasma pneumoniae (MP) is a common cause of community-acquired pneumonia (CAP) in children. MP Serum IgM and polymerase chain reaction (PCR) are the methods that enable early diagnosis in patients with MP pneumonia. The objective of this study was to investigate the clinical value of serum MP-specific IgM antibodies in PCR-positive MP pneumonia for the early diagnosis of MP pneumonia in children with CAP. Methods: Out of 129 patients with lower respiratory tract infection aged over 3 years, 90 CAP children were enrolled in the study. Throat swab MP real-time PCR and serum enzyme-linked immunosorbent assays (ELISA) IgM antibodies were performed. A positive rate of MP PCR and serum IgM, the level of IgM index, clinical features, and laboratory findings were analyzed. Results: MP PCR was positive in 57 cases. Longer fever duration before admission (P<0.001), higher rates of lobar or segmental pneumonia (P=0.048), unilateral infiltration (P=0.038), and extrapulmonary symptoms (P=0.049) were associated with MP PCR-positive pneumonia. Serum IgM index was significantly higher in MP PCR-positive pneumonia them in MP PCR-negative pneumonia (3.9±3.0 vs. 0.8±1.3, P<0.001). Using MP PCR as a gold standard, the sensitivity, specificity, positive predictive value and negative predictive value of serum IgM were 85.5%, 82.1%, 91.4%, and 71.9%, respectively. The area under the curves for serum IgM index was 0.892, and the ROC analysis indicated that an optimal cutoff value of 1.05 for serum IgM provided the highest sensitivity and specificity interestingly (83.9% vs. 85.7%, P<0.001). Conclusion: Serum IgM ELISA has useful diagnostic value in PCR-positive MP pneumonia. Applying an IgM index cutoff of 1.05 improves diagnostic accuracy.
Abstract
Purpose: Mycoplasma pneumoniae (MP) is a common cause of community-acquired pneumonia (CAP) in children. MP Serum IgM and polymerase chain reaction (PCR) are the methods that enable early diagnosis in patients with MP pneumonia. The objective of this study was to investigate the clinical value of serum MP-specific IgM antibodies in PCR-positive MP pneumonia for the early diagnosis of MP pneumonia in children with CAP. Methods: Out of 129 patients with lower respiratory tract infection aged over 3 years, 90 CAP children were enrolled in the study. Throat swab MP real-time PCR and serum enzyme-linked immunosorbent assays (ELISA) IgM antibodies were performed. A positive rate of MP PCR and serum IgM, the level of IgM index, clinical features, and laboratory findings were analyzed. Results: MP PCR was positive in 57 cases. Longer fever duration before admission (P<0.001), higher rates of lobar or segmental pneumonia (P=0.048), unilateral infiltration (P=0.038), and extrapulmonary symptoms (P=0.049) were associated with MP PCR-positive pneumonia. Serum IgM index was significantly higher in MP PCR-positive pneumonia them in MP PCR-negative pneumonia (3.9±3.0 vs. 0.8±1.3, P<0.001). Using MP PCR as a gold standard, the sensitivity, specificity, positive predictive value and negative predictive value of serum IgM were 85.5%, 82.1%, 91.4%, and 71.9%, respectively. The area under the curves for serum IgM index was 0.892, and the ROC analysis indicated that an optimal cutoff value of 1.05 for serum IgM provided the highest sensitivity and specificity interestingly (83.9% vs. 85.7%, P<0.001). Conclusion: Serum IgM ELISA has useful diagnostic value in PCR-positive MP pneumonia. Applying an IgM index cutoff of 1.05 improves diagnostic accuracy.
참고문헌 (38)
- Liu WK, "Epidemiology of acute respiratory infections in children in Guangzhou: a three- year study", PLoS One, 9, pp.e96674~ (2014)[DOI]
- He XY, "Investigation of Mycoplasma pneumoniae infection in pediatric population from 12,025 cases with respiratory infection", Diagn Microbiol Infect Dis, 75, pp.22~27 (2013)[DOI]
- 양은애, "소아 대엽성 폐렴에서 마이코플라즈마 폐렴의 임상적 특성", Allergy Asthma & Respiratory Disease, 22(3), pp.256~264 (2012), 대한 소아알레르기 호흡기학회
- 박가영, "소아 마이코플라스마 폐렴에서 흉부 방사선 소견에 따른 임상 양상의 차이", Allergy Asthma & Respiratory Disease, 1(4), pp.362~369 (2013), 대한 소아알레르기 호흡기학회
- 김경원, "국내 마이코플라스마와 클라미디아 감염 - 폐렴을 중심으로 -", Clinical and Experimental Pediatrics, 52(3), pp.277~282 (2009), 대한소아청소년과학회
- Izumikawa K, "Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: a review of the Japanese literature", J Infect Chemother, 20, pp.181~185 (2014)[DOI]
- Pellan M, "Pulmonary necrotizing cavity caused by Mycoplasma pneumoniae infection", Arch Pediatr, 20, pp.1158~1159 (2013)[DOI]
- Mishra R, "An interesting case of mycoplasma pneumonia associated multisystem involvement and diffuse alveolar hemorrhage", Respir Med Case Rep, 21, pp.78~81 (2017)
- Izumikawa K, "Clinical features of severe or fatal Mycoplasma pneumoniae Pneumonia", Front Microbiol, 7, pp.800~ (2016)
- Narita M, "Classification of extrapulmonary manifestations due to Mycoplasma pneumoniae Infection on the basis of possible pathogenesis", Front Microbiol, 7, pp.23~ (2016)
- Topcu Y, "Coexistence of myositis, transverse myelitis, and Guillain Barre syndrome following Mycoplasma pneumoniae infection in an adolescent", J Pediatr Neurosci, 8, pp.59~63 (2013)[DOI]
- Khoury T, "Increased rates of intensive care unit admission in patients with Mycoplasma pneumoniae: a retrospective study", Clin Microbiol Infect, 22, pp.711~714 (2016)[DOI]
- Hon KL, "Typical or atypical pneumonia and severe acute respiratory symptoms in PICU", Clin Respir J, 9, pp.366~371 (2015)[DOI]
- Morozumi M, "Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia", J Infect Chemother, 16, pp.78~86 (2010)[DOI]
- 이은, "Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children", Clinical and Experimental Pediatrics, 60(5), pp.151~157 (2017), 대한소아청소년과학회
- 윤유숙, "Early Additional Immune-Modulators for Mycoplasma pneumoniae Pneumonia in Children: An Observation Study", Infection and Chemotherapy, 46(4), pp.239~247 (2014), 대한감염학회[DOI]
- Tamura A, "Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children", J Infect, 57, pp.223~228 (2008)[DOI]
- Yan Y, "The clinical characteristics of corticosteroid-resistant refractory Mycoplasma pneumoniae pneumonia in children", Sci Rep, 6, pp.39929~ (2016)[DOI]
- Qasem JA, "Polymerase chain reaction as a sensitive and rapid method for specific detection of Mycoplasma pneumoniae in clinical samples", Microbiol Res, 157, pp.77~82 (2002)[DOI]
- Miyashita N, "Rapid diagnostic method for the identification of Mycoplasma pneumoniae respiratory tract infection", J Infect Chemother, 22, pp.327~330 (2016)[DOI]
- Yin YD, "Evaluation of the Japanese Respiratory Society guidelines for the identification of Mycoplasma pneumoniae pneumonia", Respirology, 17, pp.1131~1136 (2012)[DOI]
- McIntosh K, "Community-acquired pneumonia in children", N Engl J Med, 346, pp.429~437 (2002)[DOI]
- 이규택, "제주 지역 소아에서 폐렴미코플라스마(Mycoplasma pneumoniae) IgM 항체의 혈청빈도", Laboratory Medicine Online, 4(3), pp.146~151 (2014), 대한진단검사의학회
- Miyashita N, "Diagnostic sensitivity of a rapid antigen test for the detection of Mycoplasma pneumoniae: comparison with real-time PCR", J Infect Chemother, 21, pp.473~475 (2015)[DOI]
- Ferwerda A, "Respiratory tract infections by Mycoplasma pneumoniae in children: a review of diagnostic and therapeutic measures", Eur J Pediatr, 160, pp.483~491 (2001)[DOI]
- Liu FC, "Do serological tests provide adequate rapid diagnosis of Mycoplasma pneumoniae infection?", Jpn J Infect Dis, 61, pp.397~399 (2008)
- Sillis M, "The limitations of IgM assays in the serological diagnosis of Mycoplasma pneumoniae infections", J Med Microbiol, 33, pp.253~258 (1990)[DOI]
- Talkington DF, "Analysis of eight commercial enzyme immunoassay tests for detection of antibodies to Mycoplasma pneumoniae in human serum", Clin Diagn Lab Immunol, 11, pp.862~867 (2004)
- Waites KB, "Mycoplasma pneumoniae and its role as a human pathogen", Clin Microbiol Rev, 17, pp.697~728 (2004)[DOI]
- Nadal D, "Community-acquired pneumonia in children due to Mycoplasma pneumoniae: diagnostic performance of a seminested 16S rDNA-PCR", Diagn Microbiol Infect Dis, 39, pp.15~19 (2001)[DOI]
- Honda J, "Clinical use of capillary PCR to diagnose Mycoplasma pneumonia", J Clin Microbiol, 38, pp.1382~1384 (2000)
- Kakuya F, "Comparison of oropharyngeal and nasopharyngeal swab specimens for the detection of Mycoplasma pneumoniae in children with lower respiratory tract infection", J Pediatr, 189, pp.218~221 (2017)[DOI]
- Reznikov M, "Comparison of nasopharyngeal aspirates and throat swab specimens in a polymerase chain reaction-based test for Mycoplasma pneumoniae", Eur J Clin Microbiol Infect Dis, 14, pp.58~61 (1995)[DOI]
- Hsieh SC, "Mycoplasma pneumonia: clinical and radiographic features in 39 children", Pediatr Int, 49, pp.363~367 (2007)[DOI]
- 위화현, "최근 3번의 대유행 동안 한국 소아에서 발생한마이코플라즈마 폐렴의 임상적 특징", Allergy Asthma & Respiratory Disease, 5(1), pp.8~14 (2017), 대한 소아알레르기 호흡기학회[DOI]
- Gao J, "Epidemiology and clinical features of segmental", lobar pattern Mycoplasma pneumoniae pneumonia: a ten-year retrospective clinical study, 2015, pp.10, 2337~2344
- Waris ME, "Diagnosis of Mycoplasma pneumoniae pneumonia in children", J Clin Microbiol, 36, pp.3155~3159 (1998)
- Thurman KA, "Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks", Clin Infect Dis, 48, pp.1244~1249 (2009)[DOI]
